Home » Archive

News

Marketwire, News, Syndication »

SG Biofuels Opens Expanded Headquarters & Genomics Research Center to Support Commercial Advancements

Posted by Mary Canady June 12th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 12, 2012) – SG Biofuels, Inc. (SGB), an energy crop company delivering high performance bioenergy solutions for the renewable fuel, biomass and chemical markets, has opened an expanded corporate headquarters and geno…

More...

News, Syndication, Xconomy »

JOBS Act: Important Benefits for Startups Not on the IPO On-Ramp

Posted by sandiegobiotech June 12th, 2012 .
No Comments

The JOBS Act is probably best-known for creating an “IPO on ramp” intended to reduce the cost and complexity of going public, but the act also contains important benefits for startups that are years…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Shire Unveils Plan for SD Campus, Regenerative Medicine Expansion

Posted by sandiegobiotech June 11th, 2012 .
No Comments

Shire (NASDAQ: SHPGY), the Irish drug giant that acquired San Diego’s Advanced BioHealing a year ago, says today it has been working with San Diego-based BioMed Realty Trust to develop a corporate…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Ready or Not, Genomics is Coming to a Hospital Near You

Posted by sandiegobiotech June 11th, 2012 .
No Comments

First came genomics for scientists. Then came genomics for Big Pharma. But this year, at a faster pace than many industry insiders anticipated, we’re seeing genomics enter the world of real-life care…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

SD Biotech Roundup: Astute Raises $40M, Correlation Tries New VC Model

Posted by sandiegobiotech June 7th, 2012 .
No Comments

Here’s a short, but interesting roundup of life sciences news over the past week. —San Diego-based Astute Medical, which targets certain biomarkers to rapidly diagnose sepsis and other acute…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group’s Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property

Posted by Mary Canady June 7th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 7, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today that its wholly owned subsidiary Regen BioPharma, Inc. has executed an exclusive option agreement which grants Regen BioPh…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group’s Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property

Posted by Mary Canady June 7th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 7, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today that its wholly owned subsidiary Regen BioPharma, Inc. has executed an exclusive option agreement which grants Regen BioPh…

More...

News, Syndication, Xconomy »

A Big Crowd and Signs of Increasing VC Activity Mark SD Venture Summit

Posted by sandiegobiotech June 6th, 2012 .
No Comments

“Clearly, there’s more activity here today than there was a year or two ago,” Dave Titus said as he was making final preparations for today’s San Diego Venture Group Summit. As a litmus test for San…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Emerging Challenges of Prostate Cancer Drug Development

Posted by sandiegobiotech June 6th, 2012 .
No Comments

The world’s largest cancer meeting of scientists, physicians and industry has just ended in Chicago. The annual meeting of the American Society of Clinical Oncology (ASCO) attracted over 30,000…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Bio-Matrix’ Regen BioPharma Unit Establishes Scientific Advisory Board and Research Relationship With Clinartis in Anticipation of Beginning Clinical Development Stem Cell Studies

Posted by Mary Canady June 6th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 6, 2012) –

World renowned experts to accelerate development of stem cell therapeutics

Regen anticipates new relationship with Clinartis to fast track clinical studies

More...